NOV
58
3
TRV
53
-3
SCHW
64
2
COP
56
2
MCO
73
3
DVA
72
2
HP
38
-2
AVGO
20
-5
FLS
73
-2
HRL
39
15
TEL
60
2
EQIX
60
-2
HIG
67
4
BMY
53
-7
EL
20
3
INTU
51
2
COST
58
-2
CF
59
3
HON
65
-2
PDCO
35
-3
NOV
58
3
TRV
53
-3
SCHW
64
2
COP
56
2
MCO
73
3
DVA
72
2
HP
38
-2
AVGO
20
-5
FLS
73
-2
HRL
39
15
TEL
60
2
EQIX
60
-2
HIG
67
4
BMY
53
-7
EL
20
3
INTU
51
2
COST
58
-2
CF
59
3
HON
65
-2
PDCO
35
-3
Financhill
Back

Novo Nordisk AS Vs. Ascendis Pharma AS Industry Stock Comparison

Sell
34

NONOF
Novo Nordisk AS

Last Price:
105.49
Seasonality Move:
10.92%
Sell
20

ASND
Ascendis Pharma AS

Last Price:
124.46
Seasonality Move:
20.86%
Sell
34
Novo Nordisk AS (NONOF) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NONOF] share price is $105.49. The Score for NONOF is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • NONOF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
20
Ascendis Pharma AS (ASND) is a Sell

Is Ascendis Pharma AS a Buy, Sell or Hold?

  • The current Ascendis Pharma AS [ASND] share price is $124.38. The Score for ASND is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • ASND is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

NONOF Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $105.49
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing buying pressure, which is a positive indicator for future bullish movement.

ASND Stock Price Chart

What is Ascendis Pharma AS's stock price today?

  • The Ascendis Pharma AS share price today is $124.38
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ASND is experiencing slight buying pressure.

NONOF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.96 Sell
Relative Strength Index (14 RSI): 42.96 Sell
Chaikin Money Flow: 32377 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (104.78 - 115) Sell
Bollinger Bands (100): (113.85 - 136.93) Sell

ASND Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.98 Sell
Relative Strength Index (14 RSI): 44.33 Sell
Chaikin Money Flow: 89072 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (124.33 - 129.33) Sell
Bollinger Bands (100): (124.53 - 141.57) Sell

NONOF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 104.24 Buy
20-day SMA: 108.18 Sell
50-day SMA: 116.71 Sell
200-day SMA: 127.84 Sell
8-day EMA: 104.48 Buy
20-day EMA: 107.97 Sell
50-day EMA: 115.05 Sell
200-day EMA: 120.69 Sell

ASND Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 125.5 Sell
20-day SMA: 126.25 Sell
50-day SMA: 132.55 Sell
200-day SMA: 136.92 Sell
8-day EMA: 124.99 Sell
20-day EMA: 126.65 Sell
50-day EMA: 129.84 Sell
200-day EMA: 130.32 Sell

Novo Nordisk AS Earnings Growth & NONOF Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.55 per share.

Ascendis Pharma AS Earnings Growth & ASND Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.63 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.89 per share, and an increase next year of $4.01 per share.

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ascendis Pharma AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):